DNTH
NASDAQ · Biotechnology
Dianthus Therapeutics Inc
$95.26
-1.55 (-1.60%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+151.54%
YTD
+140.07%
Open$95.96
Previous Close$96.81
Day High$97.46
Day Low$94.58
52W High$117.88
52W Low$32.22
Volume—
Avg Volume723.5K
Market Cap5.66B
P/E Ratio—
EPS$-4.15
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$45.37
Above
SMA 200
$31.95
Above
RSI (14)
42.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-59.2% upside
Current
$95.26
$95.26
Target
$38.82
$38.82
$27.89
$38.82 avg
$53.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.95M | 305.72M | 270.76M |
| Net Income | -235,597,328 | -32,339,215 | -26,813,974 |
| Profit Margin | -7,973.3% | -10.6% | -9.9% |
| EBITDA | -258,071,465 | -32,605,970 | -27,281,394 |
| Free Cash Flow | — | -20,890,110 | -21,520,158 |
| Rev Growth | — | +9.7% | -3.3% |
| Debt/Equity | — | 0.57 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |